Literature DB >> 511353

General survey of trimethoprim combinations in the treatment of urinary tract infections.

W Brumfitt, J M Hamilton-Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 511353     DOI： 10.1007/bf01639018

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  42 in total

1.  Kinetics of a sulfadiazine-trimethoprim combination.

Authors:  T Bergan; H Vik-Mo; U Anstad
Journal:  Clin Pharmacol Ther       Date:  1977-08       Impact factor: 6.875

2.  The purification and properties of the trimethoprim-resistant dihydrofolate reductase mediated by the R-factor, R388.

Authors:  S G Amyes; J T Smith
Journal:  Eur J Biochem       Date:  1976-01-15

3.  Comparison of long-term, low-dosage nitrofurantoin, methenamine hippurate, trimethoprim and trimethoprim-sulphamethoxazole on the control of recurrent urinary tract infection.

Authors:  A Kasanen; E Kaarsalo; R Hiltunen; V Soini
Journal:  Ann Clin Res       Date:  1974-10

4.  Absorption and urinary execretion of trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole: results with single doses in normal young adults and preliminary observations during therapy with trimethoprim-sulfamethoxazole.

Authors:  M C Bach; O Gold; M Finland
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

5.  Trimethoprim metabolites in rat, dog and man: qualitative and quantitative studies.

Authors:  D E Schwartz; W Vetter; G Englert
Journal:  Arzneimittelforschung       Date:  1970-12

6.  Trimethoprim--resistant coliforms.

Authors: 
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

7.  Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.

Authors:  K Fruensgaard; B Korner
Journal:  Chemotherapy       Date:  1974       Impact factor: 2.544

8.  Human infections with thymine-requiring bacteria.

Authors:  R Maskell; O A Okubadejo; R H Payne; L Pead
Journal:  J Med Microbiol       Date:  1978-02       Impact factor: 2.472

9.  Effect of thymidine on activity of trimethoprim and sulphamethoxazole.

Authors:  A Stokes; R W Lacey
Journal:  J Clin Pathol       Date:  1978-02       Impact factor: 3.411

10.  Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection.

Authors:  J D Anderson; R W Lacey; E L Lewis; M A Sellin
Journal:  J Clin Pathol       Date:  1974-08       Impact factor: 3.411
View more
  6 in total

1.  Trimethoprim/sulphonamide: concluding remarks.

Authors:  W Marget
Journal:  Infection       Date:  1979       Impact factor: 3.553

2.  Pharmacokinetics of co-trimoxazole and co-tetroxazine in geriatric patients.

Authors:  K Naber; H Vergin; W Weigand
Journal:  Infection       Date:  1981       Impact factor: 3.553

3.  Comparative trial of trimethoprim and co-trimoxazole in recurrent urinary infections.

Authors:  W Brumfitt; J M Hamilton-Miller; H Ludlam; V Damjanovic; R Gargan
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

Review 4.  The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues.

Authors:  D S Reeves; P J Wilkinson
Journal:  Infection       Date:  1979       Impact factor: 3.553

5.  Effect of changing selection pressures on trimethoprim resistance in Enterobacteriaceae.

Authors:  K J Towner; R C Slack
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

Review 6.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.